Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine

Objective Enzymatic degradation of the extracellular matrix is known to be powerful regulator of atherosclerosis. However, little is known about the enzymatic regulation of heparan sulfate proteoglycans (HSPGs) during the formation and progression of atherosclerotic plaques. Methods and results S...

Full description

Bibliographic Details
Main Authors: Baker, Aaron B., Chatzizisis, Yiannis S., Beigel, Roy, Jonas, Michael, Stone, Benjamin V., Coskun, Ahmet U., Maynard, Charles, Rogers, Campbell, Koskinas, Konstantinos C., Feldman, Charles L., Stone, Peter H., Edelman, Elazer R.
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: Elsevier 2015
Online Access:http://hdl.handle.net/1721.1/99184
https://orcid.org/0000-0002-7832-7156
_version_ 1826201308805201920
author Baker, Aaron B.
Chatzizisis, Yiannis S.
Beigel, Roy
Jonas, Michael
Stone, Benjamin V.
Coskun, Ahmet U.
Maynard, Charles
Rogers, Campbell
Koskinas, Konstantinos C.
Feldman, Charles L.
Stone, Peter H.
Edelman, Elazer R.
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Baker, Aaron B.
Chatzizisis, Yiannis S.
Beigel, Roy
Jonas, Michael
Stone, Benjamin V.
Coskun, Ahmet U.
Maynard, Charles
Rogers, Campbell
Koskinas, Konstantinos C.
Feldman, Charles L.
Stone, Peter H.
Edelman, Elazer R.
author_sort Baker, Aaron B.
collection MIT
description Objective Enzymatic degradation of the extracellular matrix is known to be powerful regulator of atherosclerosis. However, little is known about the enzymatic regulation of heparan sulfate proteoglycans (HSPGs) during the formation and progression of atherosclerotic plaques. Methods and results Swine were rendered diabetic through streptozotocin injection and hyperlipidemic through a high fat diet. Arterial remodeling and local endothelial shear stress (ESS) were assessed using intravascular ultrasound, coronary angiography and computational fluid dynamics at weeks 23 and 30. Coronary arteries were harvested and 142 arterial subsegments were analyzed using histomorphologic staining, immunostaining and real time PCR. Heparanase staining and activity was increased in arterial segments with low ESS, in lesions with thin cap fibroatheroma (TCFA) morphology and in lesions with severely degraded internal elastic laminae. In addition, heparanase staining co-localized with staining for CD45 and MMP-2 within atherosclerotic plaques. Dual staining with gelatinase zymography and heparanase immunohistochemical staining demonstrated co-localization of matrix metalloprotease activity with heparanase staining. A heparanase enzymatic activity assay demonstrated increased activity in TCFA lesions, subsegments with low ESS and in macrophages treated with oxidized LDL or angiotensin II. Conclusions Taken together, our results support a critical role for heparanase in the development of vulnerable plaques and suggest a novel therapeutic target for the treatment of atherosclerosis.
first_indexed 2024-09-23T11:49:33Z
format Article
id mit-1721.1/99184
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:49:33Z
publishDate 2015
publisher Elsevier
record_format dspace
spelling mit-1721.1/991842022-09-27T22:09:23Z Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine Baker, Aaron B. Chatzizisis, Yiannis S. Beigel, Roy Jonas, Michael Stone, Benjamin V. Coskun, Ahmet U. Maynard, Charles Rogers, Campbell Koskinas, Konstantinos C. Feldman, Charles L. Stone, Peter H. Edelman, Elazer R. Harvard University--MIT Division of Health Sciences and Technology Beigel, Roy Jonas, Michael Stone, Benjamin V. Edelman, Elazer R. Objective Enzymatic degradation of the extracellular matrix is known to be powerful regulator of atherosclerosis. However, little is known about the enzymatic regulation of heparan sulfate proteoglycans (HSPGs) during the formation and progression of atherosclerotic plaques. Methods and results Swine were rendered diabetic through streptozotocin injection and hyperlipidemic through a high fat diet. Arterial remodeling and local endothelial shear stress (ESS) were assessed using intravascular ultrasound, coronary angiography and computational fluid dynamics at weeks 23 and 30. Coronary arteries were harvested and 142 arterial subsegments were analyzed using histomorphologic staining, immunostaining and real time PCR. Heparanase staining and activity was increased in arterial segments with low ESS, in lesions with thin cap fibroatheroma (TCFA) morphology and in lesions with severely degraded internal elastic laminae. In addition, heparanase staining co-localized with staining for CD45 and MMP-2 within atherosclerotic plaques. Dual staining with gelatinase zymography and heparanase immunohistochemical staining demonstrated co-localization of matrix metalloprotease activity with heparanase staining. A heparanase enzymatic activity assay demonstrated increased activity in TCFA lesions, subsegments with low ESS and in macrophages treated with oxidized LDL or angiotensin II. Conclusions Taken together, our results support a critical role for heparanase in the development of vulnerable plaques and suggest a novel therapeutic target for the treatment of atherosclerosis. Novartis (Firm) Boston Scientific Corporation National Institutes of Health (U.S.) (Grant R01 GM49039) 2015-10-07T15:49:33Z 2015-10-07T15:49:33Z 2010-09 2010-08 Article http://purl.org/eprint/type/JournalArticle 00219150 http://hdl.handle.net/1721.1/99184 Baker, Aaron B., Yiannis S. Chatzizisis, Roy Beigel, Michael Jonas, Benjamin V. Stone, Ahmet U. Coskun, Charles Maynard, et al. “Regulation of Heparanase Expression in Coronary Artery Disease in Diabetic, Hyperlipidemic Swine.” Atherosclerosis 213, no. 2 (December 2010): 436–442. https://orcid.org/0000-0002-7832-7156 en_US http://dx.doi.org/10.1016/j.atherosclerosis.2010.09.003 Atherosclerosis Creative Commons Attribution-Noncommercial-NoDerivatives http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier PMC
spellingShingle Baker, Aaron B.
Chatzizisis, Yiannis S.
Beigel, Roy
Jonas, Michael
Stone, Benjamin V.
Coskun, Ahmet U.
Maynard, Charles
Rogers, Campbell
Koskinas, Konstantinos C.
Feldman, Charles L.
Stone, Peter H.
Edelman, Elazer R.
Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title_full Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title_fullStr Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title_full_unstemmed Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title_short Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine
title_sort regulation of heparanase expression in coronary artery disease in diabetic hyperlipidemic swine
url http://hdl.handle.net/1721.1/99184
https://orcid.org/0000-0002-7832-7156
work_keys_str_mv AT bakeraaronb regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT chatzizisisyianniss regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT beigelroy regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT jonasmichael regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT stonebenjaminv regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT coskunahmetu regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT maynardcharles regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT rogerscampbell regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT koskinaskonstantinosc regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT feldmancharlesl regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT stonepeterh regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine
AT edelmanelazerr regulationofheparanaseexpressionincoronaryarterydiseaseindiabetichyperlipidemicswine